Joseph A. Madri, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 30,000 shares at $115.00 ($3.5M) on 2013-09-16, disclosed to the SEC on 2013-09-18.
Scheduled sale ($3.5M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ALXN | SELL | 2012-08-07 | $3.2M | — | Filing → |
| ALXN | SELL | 2012-03-01 | $1.3M | — | Filing → |
| ALXN | SELL | 2011-07-28 | $1.7M | — | Filing → |